Understand the source comparison
How to Use Peptides for Focus: Comparison Across Mechanism Classes
This table compares nootropic peptide categories by primary mechanism, onset timeline, and cognitive domain targeted. Essential context for matching compounds to specific focus deficits. BDNF Modulators (Dihexa, P21) Upregulate brain-derived neurotrophic facto
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- This table compares nootropic peptide categories by primary mechanism, onset timeline, and cognitive domain targeted. Essential context for matching compounds to specific focus deficits.
- BDNF Modulators (Dihexa, P21)
- Upregulate brain-derived neurotrophic factor receptors and dendritic spine density
- 14–21 days for measurable cognitive shift
- Learning retention, synaptic plasticity, long-term memory consolidation
- Every 48–72 hours over 3–4 weeks
- Best for structural cognitive enhancement. Not acute focus. Requires patience and consistent dosing.
- Neurotrophic Peptide Blends (Cerebrolysin)
- Multi-peptide formulation enhances ACh receptor expression, glucose metabolism, and neuroprotection
- 7–14 days for sustained attention improvement
- Sustained attention, cholinergic function, neuroprotection in aging or metabolic stress
- Daily or every other day for 10–20 days
- Strongest evidence base for age-related cognitive decline. Requires IM administration.
- CREB Activators (P21)
- Enhance CREB phosphorylation to support memory consolidation and hippocampal neurogenesis
- 10–14 days
- Memory encoding, hippocampal-dependent learning tasks
- Daily subcutaneous for 2–3 weeks
- Derived from CNTF. Potent but understudied in human cognitive protocols.
- Mitochondrial Enhancers (MK-677 as GH secretagogue)
- Increase growth hormone and IGF-1, which enhance neuronal mitochondrial biogenesis
- 14–28 days for cognitive effects; immediate appetite and sleep changes
- Mental stamina, recovery from sleep deprivation, neuroprotection
- Daily oral dosing at 10–25mg
- Indirect nootropic via metabolic optimisation. Works best combined with cholinergic or BDNF-targeting peptides.
- The peptides we carry at Real Peptides. Including Dihexa, Cerebrolysin, and P21. Are synthesised under strict USP standards with verified amino acid sequencing to guarantee bioactivity. Small-batch production ensures freshness and eliminates the potency degradation common in bulk-manufactured research compounds.